Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Impact of Artificial Intelligence-Based Health Education on Self-Efficacy, Self-Care Behaviors, and Glycemic Control in Diabetic Patients

NCT06985680 is registered in ClinicalTrials.gov with Chia-Tzu Line as lead sponsor.

NCT NCT06985680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06985680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Impact of Artificial Intelligence-Based Health Education on Self-Efficacy, Self-Care Behaviors, and Glycemic Control in Diabetic Patients
Lead sponsor
Chia-Tzu Line
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2024
Completion date
February 18, 2025
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic patients,self-care,artificial intelligence-based,self-efficacy, type 2 diabetes mellitus (t2dm)